Showing results (831-840 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|November 20, 2025
Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World StudyTeresa Ramirez-Garcia, Pablo Cabezudo-Garcia, Guillermina Garcia-Martin, et al.
Neurology and Therapy|November 27, 2025
Care Partners' Perceptions of Amyloid-Targeting Therapy and Treat‑to‑Clearance for Alzheimer's Disease in Japan: A Qualitative StudySadao Katayama, Masashi Tsujimoto, Keisuke Suzuki, et al.
Neurology and Therapy|November 18, 2025
An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating PolyneuropathyAlphonse Hubsch, Victoria Divino, Rajiv Mallick, et al.
Neurology and Therapy|January 10, 2026
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK TrialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Neurology and Therapy|January 10, 2026
Summary of Research: Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Neurology and Therapy|October 4, 2025
Expert Guidance on Cognitive Impairment in Alzheimer's Disease: A Practical Seven-Step Approach from the United Arab EmiratesTauofik Alsaadi, Abubaker Almadani, Suhail AlRukn, et al.
Neurology and Therapy|October 5, 2025
Comparative Efficacy of Double-Filtration Plasmapheresis Versus Intravenous Methylprednisolone in Acute Attacks of Neuromyelitis Optica Spectrum Disorder: A Prospective Cohort StudyXiwen Ai, Qiuju Li, Kan Wang, et al.
Neurology and Therapy|October 1, 2025
Perspective of Disease and Treatment in Patients with Multiple Sclerosis: A Polish Multi-center StudyJustyna Chojdak-Łukasiewicz, Alina Kułakowska, Joanna Tarasiuk, et al.
Neurology and Therapy|June 18, 2020
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis PatientsAntonio Bertolotto, Serena Martire, Luca Mirabile, et al.
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEMAngel Chinea, Lilyana Amezcua, Wendy Vargas, et al.
Pageof 95